| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 461.48 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Antioneoplastic drugs are widely used in treatment of cancer, and several studies suggest acute and long-term effects associated to antineoplastic drug exposures, namely associating workplace exposure with health effects. Cytokinesis blocked micronucleus (CBMN) assay is one promising short-term genotoxicity assays for human risk assessment and their combination is recommended to monitor populations chronically exposed to genotoxic agents. The aim of this investigation is the genotoxicity assessment in different professionals that handle cytostatics drugs. This research is case-control blinded study constituted by 46 non-exposed subjects and 44 workers that handle antineoplastic drugs, such as pharmacists, pharmacy technicians, and nurses. It was found statistically significant increases in the genotoxicity biomarkers in exposed comparising with controls (p<0.05). The findings address the need for regular biomonitoring of personnel occupationally exposed to these drugs, confirming to an enhanced health risk assessment.
Description
Keywords
Occupational health Genotoxic assessment Antineoplastic drugs Cytostatic drugs
Citation
Ladeira C, Viegas S, Pádua M, Carolino E, Gomes MC, Brito M. Genotoxic assessment in different exposure groups working with antineoplastic agents. In Arezes PM, Baptista JS, Barroso MP, Carneiro P, Cordeiro P, Costa N, et al, editors. Occupational safety and hygiene III. London: Taylor & Francis; 2015. p. 177-80.
Publisher
Taylor & Francis